Nath Bio-Genes (India) Ltd's Q1FY26 Quarterly Results

Result Summary

• Nath Bio-Genes (India) Ltd reported a 557.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1FY26). On a year-on-year (YoY) basis, it witnessed a growth of 17.0%.
• Its expenses for the quarter were up by 506.4% QoQ and 18.6% YoY.
• The net profit increased 1322.9% QoQ and increased 11.8% YoY.
• The earnings per share (EPS) of Nath Bio-Genes (India) Ltd stood at 19.6 during Q1FY26.

Financial Statments for Q1FY26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Nath Bio-Genes (India) Ltd is a company engaged in the agricultural sector, specifically focusing on the production and distribution of seeds. It operates within the biotechnology and agriculture industry, with a product portfolio that includes hybrid and genetically modified seeds. The company is known for its research and development in seed technology, aiming to improve crop yield and quality. Recent developments in the company or industry are not available from the provided information. As of the latest quarter, Nath Bio-Genes continues to focus on enhancing its product offerings and expanding its market presence in the agricultural sector.

Revenue

For the first quarter of fiscal year 2026 (Q1FY26), Nath Bio-Genes (India) Ltd reported a total income of ₹285.46 crores. This represents a significant quarter-over-quarter (QoQ) increase of 557.0% compared to ₹43.45 crores in the fourth quarter of fiscal year 2025 (Q4FY25). On a year-over-year (YoY) basis, the total income increased by 17.0% from ₹244.01 crores in the first quarter of fiscal year 2025 (Q1FY25). These figures indicate substantial growth in the company's revenue over both the previous quarter and the same quarter last year.

Profitability

The company's profitability metrics for Q1FY26 show a positive trend. Profit Before Tax (PBT) was ₹35.88 crores, showing a remarkable QoQ increase of 1010.8% from ₹3.23 crores in Q4FY25. Year-over-year, PBT rose by 6.8% from ₹33.60 crores in Q1FY25. Profit After Tax (PAT) for Q1FY26 was reported at ₹37.28 crores, which is a significant increase of 1322.9% QoQ from ₹2.62 crores and an 11.8% increase YoY from ₹33.35 crores. The company's Earnings Per Share (EPS) also improved, rising to ₹19.60 in Q1FY26 from ₹1.90 in Q4FY25, marking a 931.6% QoQ increase, and a 12.0% YoY growth from ₹17.50 in Q1FY25.

Operating Metrics

The total expenses for Nath Bio-Genes in Q1FY26 were ₹249.60 crores, which denotes a significant rise of 506.4% QoQ from ₹41.16 crores in Q4FY25, and an 18.6% increase YoY from ₹210.40 crores in Q1FY25. The tax expense for the quarter was ₹0.66 crores, which increased by 6.5% QoQ from ₹0.62 crores and by 164.0% YoY from ₹0.25 crores. These operating metrics reflect the company's financial strategies and operational efficiencies as evidenced by the growth in expenses and tax liabilities relative to income and profit increases.